HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC
Clinical trials for HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC explained in plain language.
Never miss a new study
Get alerted when new HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC trials appear
Sign up with your email to follow new studies for HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to slash deadly complications in Kids' stem cell transplants
Disease control Not yet recruitingThis trial tests multiple new treatments to improve outcomes for children receiving a stem cell transplant. It includes children from 1 week to 18 years old who are getting a transplant. The goal is to reduce serious complications like organ failure and infections, and make trans…
Matched conditions: HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC
Phase: NA • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New combo therapy aims to keep leukemia away after transplant
Disease control Not yet recruitingThis phase 2 trial tests whether adding asciminib to standard tyrosine kinase inhibitors can prevent relapse in patients with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia or blastic phase chronic myeloid leukemia after a stem cell transplant. 45 participan…
Matched conditions: HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC
Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC